ARV-471,abemaciclib,ribociclib
Verzenio,Eli Lilly,novartis
['breast', 'bcsm']
learn at #asco23 about an umbrella trial evaluating a #protac er degrader in combination with other anticancer therapies, including cdk4/6 inhibitors, in patients with er+ #breastcancer
#bcsm #tpd #proteindegradation 
Dedicated to communicating emerging science from #Arvinas and providing disease state education to US HCPs. See our community guidelines https://t.co/4nREnTKZBF